| Literature DB >> 27994871 |
Gaëtan-Romain Joliat1, Nicolas Demartines1, Nermin Halkic1, David Petermann1, Markus Schäfer1.
Abstract
BACKGROUND: Laparoscopic distal pancreatectomy was introduced 15 years ago, but it is still not widely used. The aim of the study was to compare the postoperative complications and length of stay between open and laparoscopic distal pancreatectomy.Entities:
Keywords: Complications; Distal pancreatectomy; Laparoscopy; Length of stay; Pancreatic surgery
Year: 2016 PMID: 27994871 PMCID: PMC5153441 DOI: 10.1016/j.amsu.2016.12.001
Source DB: PubMed Journal: Ann Med Surg (Lond) ISSN: 2049-0801
Patient characteristics (medians with interquartile range and numbers with percentage).
| Distal pancreatectomy | Open N = 79 | Laparoscopy N = 26 | |
|---|---|---|---|
| Median age, | 63 (49–71) | 64 (50–73) | 0.418 |
| Median BMI | 23.9 (20.7–27.1) | 25.5 (22.8–28.4) | 0.059 |
| Gender (men/women) | 45/34 | 16/10 | 0.819 |
| ASA | 9/52/18 | 2/18/6 | 0.291 |
| DP alone/DP + splenectomy | 13/66 | 5/21 | 0.768 |
| Diabetes mellitus | 11 (14%) | 5 (19%) | 0.563 |
| Active smokers | 25 (33%) | 8 (31%) | 1 |
| Previous abdominal operations | 6 (8%) | 1 (4%) | 0.678 |
BMI: body-mass index.
ASA: American Society of Anesthesiologists.
Histopathological diagnoses.
| Distal pancreatectomy | Open N = 79 | Laparoscopy N = 26 | |
|---|---|---|---|
| Ductal adenocarcinoma | 22 (28%) | 10 (40%) | 0.333 |
| Neuro-endocrine tumor | 11 (14%) | 7 (27%) | 0.142 |
| Mucinous cystadenoma | 5 (6%) | 1 (4%) | 1 |
| Serous cystadenoma | 3 (5%) | 1 (4%) | 1 |
| Cystadenocarcinoma | 2 (3%) | 0 | 1 |
| IPMN | 2 (3%) | 2 (7%) | 0.256 |
| Other tumors | 11 (14%) | 2 (7%) | 0.511 |
| Pseudocyst | 9 (11%) | 0 | 0.108 |
| Chronic pancreatitis | 6 (7%) | 2 (7%) | 1 |
| Normal pancreatic tissue | 6 (7%) | 1 (4%) | 0.678 |
| Polycystosis | 1 (1%) | 0 | 1 |
| Ectopic spleen | 1 (1%) | 0 | 1 |
Intraductal papillary mucinous neoplasm.
Other tumors included: sarcomas (4 in the open group), metastases (2 in the open group, 1 in the laparoscopy group), gastric adenocarcinomas (2 in the open group), undifferentiated carcinoma (1 in the laparoscopy group), solid pseudopapillary tumor (1 in the open group), adenosquamous carcinoma (1 in the open group), and adrenal carcinoma (1 in the open group).
Postoperative outcomes (medians with interquartile range and numbers with percentage).
| Distal pancreatectomy | Open N = 79 | Laparoscopy N = 26 | |
|---|---|---|---|
| Overall complication | 40 (51%) | 9 (35%) | 0.179 |
| Minor (I–II) | 18 | 2 | 0.277 |
| Major (III–IV) | 22 | 7 | 0.277 |
| Mortality (V) | 2 (3%) | 0 (0%) | 1 |
| Pancreatic fistula | 15 (19%) | 5 (19%) | 1 |
| Hemorrhage | 17 (22%) | 2 (8%) | 0.147 |
| Median ICU | 0 (0–0) | 0 (0–0) | 0.761 |
| Median IC | 3 (2–4) | 1 (1–2.5) | |
| Median length of stay | 12 (8–17) | 8 (7–10) | < |
| 60-day readmission | 12 (15%) | 2 (8%) | 0.509 |
Significant P-values appear in bold in the table.
ICU: intensive care unit.
IC: intermediate care.
TNM classification of the resected adenocarcinomas in the open and laparoscopy groups.
| Distal pancreatectomy | Open N = 22 | Laparoscopy N = 10 | |
|---|---|---|---|
| Tumor stage T1/T2/T3/T4 | 1/2/18/1 | 0/3/7/0 | 0.399 |
| Node stage N0/N1 | 8/14 | 3/7 | 1 |
| Perineural invasion | 21 | 10 | 1 |
| Vascular invasion | 15 | 7 | 1 |
| Lymphatic invasion | 13 | 7 | 0.703 |
| Margins R0/R1/R2 | 15/5/2 | 8/2/0 | 0.587 |